P016 Dilemmas and Debates in Derm
DESCRIPTION
As dermatology continues to evolve, so do the ethical challenges surrounding how we select, train, and evaluate the next generation of dermatologists. This interactive session will explore pressing ethical issues in medical student and resident education, focusing on fairness, professionalism, and accountability. Topics will include the implications of Step 1 and Step 2 pass/fail scoring, equity and merit in the residency selection process, managing learner errors, the ethics of recommendation letters and ranking systems, and the growing influence of social media in applicant evaluation. Attendees will gain practical tools for navigating ethically complex situations in education and mentorship.
LEARNING OBJECTIVES
Identify ethical dilemmas that practicing dermatologists in 2025 encounter on a regular basis.
Using ethical frameworks, outline arguments for and against the ways to address these dilemmas.
Apply techniques by which dermatologists can navigate ethical dilemmas in their daily practice.
SCHEDULE
6:00 PM
Introduction
Stephanie Fabbro, MD, FAAD
6:10 PM
Hype, Hashtags, and Hippocrates: Ethics in Dermatology’s Digital Age
Elizabeth A. Kiracofe, MD, FAAD
6:30 PM
How to factor in equity and diversity in the interview process
Cheryl M. Burgess, MD, FAAD
6:50 PM
Forgive and Remember: When Medical Students and Residents make errors
Anne Louise Housholder, MD, FAAD
7:10 PM
Ethics of the token system for ranking / Issues surrounding letters of recommendation
Stephanie Mengden, MD, FAAD
7:30 PM
Ethics of making step 1, 2 pass/fail and how that changes the derm applicant process
7:50 PM
Reviewing applicants' social media presence when determining to interview them or how to rank them
Stephanie Fabbro, MD, FAAD
SPEAKERS
Cheryl M. Burgess, MD, FAAD
Center for Dermatology and Dermatologic Surgery
Stephanie Fabbro, MD, FAAD
Anne Louise Housholder, MD, FAAD
Elizabeth A. Kiracofe, MD, FAAD
Stephanie Mengden, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Cheryl M. Burgess, MD, FAAD
Aerolase – Investigator(Equipment); Allergan, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Prollenium – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Target Cool – Advisory Board(Equipment); TEOXANE Laboratories – Investigator(Grants/Research Funding);
Stephanie Fabbro, MD, FAAD
Beiersdorf – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Kyowa Kirin – Speaker(Honoraria);
Anne Louise Housholder, MD, FAAD
PatientPoint – Consultant(Honoraria);
Elizabeth A. Kiracofe, MD, FAAD
Arcutis Biotherapeutics – Speaker(Fees); CeraVe – Consultant (1099 relationship)(Honoraria); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly – Speaker(Fees); Galderma – Speaker(Fees); Incyte Corporation – Speaker(Fees); Sanofi/Regeneron – Speaker(Fees); UCB – Speaker(Fees);
Stephanie Mengden, MD, FAAD
No financial relationships exist with ineligible companies.